Secondary surgical resection for patients with recurrent uterine leiomyosarcoma-Reference-Cited by-同舟云学术

Secondary surgical resection for patients with recurrent uterine leiomyosarcoma

Published:2019-08 Issue:2 Volume:154 Page:333-337
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Cybulska Paulina,Sioulas Vasileios,Orfanelli Theofano,Zivanovic Oliver,Mueller Jennifer J.,Broach Vance A.,Long Roche Kara C.,Sonoda Yukio,Hensley Martee L.,O'Cearbhaill Roisin E.,Chi Dennis S.,Alektiar Kaled M.,Abu-Rustum Nadeem R.,Leitao Mario M.

Funder

NIH

NCI

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation;Ricci;Gynecol. Oncol.,2017

2. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus;Leitao;Gynecol. Oncol.,2003

3. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study;Sutton;Gynecol. Oncol.,1996

4. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas;Omura;Cancer,1983

5. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group);Muss;Cancer,1985

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Treatment Options: Uterine Sarcoma;Current Treatment Options in Oncology;2024-05-31

2. Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery;BMC Women's Health;2024-01-02

3. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma;Annals of Surgical Oncology;2023-09-01

4. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS);Therapeutic Advances in Medical Oncology;2023-01

5. Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021);Geburtshilfe und Frauenheilkunde;2022-12